John R. Haines - 17 Feb 2025 Form 4 Insider Report for Celularity Inc (CELU)

Role
Senior Exec Vice President
Signature
/s/ John Haines
Issuer symbol
CELU
Transactions as of
17 Feb 2025
Net transactions value
-$15,055
Form type
4
Filing time
19 Feb 2025, 17:00:19 UTC
Previous filing
16 Apr 2024
Next filing
15 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CELU Class A Common Stock Options Exercise $0 +20,000 +133% $0.000000 35,092 17 Feb 2025 Direct F1
transaction CELU Class A Common Stock Tax liability $15,055 -7,035 -20% $2.14 28,057 17 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CELU Restricted Stock Units Options Exercise $0 -20,000 -100% $0.000000 0 17 Feb 2025 Class A Common Stock 20,000 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the conversion upon vesting of restricted stock units (RSUs) into Class A common stock. On February 17, 2023, the reporting person was granted 20,000 RSUs, which vested on February 17, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on February 22, 2023.
F2 This line reflects the tax withholding on the vesting of RSUs that vested on February 17, 2025.
F3 Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock.
F4 On February 17, 2023, the reporting person was granted 20,000 RSUs, which vested on February 17, 2025. The Class a common stock into which such vested RSUs converted on February 17, 2025 is reported in Table I on this Form 4.